Literature DB >> 19955821

Advantages of new hemodialysis membranes and equipment.

R Vanholder1, G Glorieux, W Van Biesen.   

Abstract

Chronic kidney disease is characterized by the progressive retention of a number of compounds, several of which have the potential to cause cardiovascular damage. Many of these are difficult to remove by standard dialysis strategies. Removal of the larger middle molecules (mostly larger peptidic compounds) can be obtained by increasing dialyzer pore size and/or by applying convective strategies. For protein-bound solutes, convection (essentially hemodiafiltration) positively affects removal. The HEMO study demonstrated outcome superiority for the large-pore high-flux hemodialysis membranes in a number of subgroup analyses. Likewise, the Membrane Permeability Outcome study showed outcome superiority for high flux in patients with serum albumin <4 g/dl, the group for which the study had originally been designed. Apart from a small controlled trial, data suggesting superiority for convective strategies are all observational. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955821     DOI: 10.1159/000262298

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  6 in total

Review 1.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

2.  An experimental and theoretical analysis of molecular separations by diffusion through ultrathin nanoporous membranes.

Authors:  J L Snyder; A Clark; D Z Fang; T R Gaborski; C C Striemer; P M Fauchet; J L McGrath
Journal:  J Memb Sci       Date:  2011-03-01       Impact factor: 8.742

Review 3.  Flummoxed by flux: the indeterminate principles of haemodialysis.

Authors:  Sudhir K Bowry; Fatih Kircelli; Madhukar Misra
Journal:  Clin Kidney J       Date:  2021-12-27

Review 4.  The membrane perspective of uraemic toxins: which ones should, or can, be removed?

Authors:  Sudhir K Bowry; Peter Kotanko; Rainer Himmele; Xia Tao; Michael Anger
Journal:  Clin Kidney J       Date:  2021-12-27

5.  The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients.

Authors:  Stefania Caria; Adamasco Cupisti; Giovanna Sau; Piergiorgio Bolasco
Journal:  BMC Nephrol       Date:  2014-10-29       Impact factor: 2.388

Review 6.  Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability.

Authors:  Christian Apel; Carsten Hornig; Frank W Maddux; Terry Ketchersid; Julianna Yeung; Adrian Guinsburg
Journal:  Clin Kidney J       Date:  2021-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.